Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil dose comparison and tadalafil + tamsulosin combination study in lower urinary tract symptoms due to benign prostatic hyperplasia
PACTR202506840472754Phase 2Recruiting
- Sponsor
- Tanta University Hospitals
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tadalafil and tamsulosin in benign prostatic hyperplasia (BPH) and Micturition disorder, sponsored by Tanta University Hospitals. Primary endpoint: Change in International Prostate Symptom Score. Started Jun 2025; status: recruiting.
02
Drugs
tadalafiltamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)Micturition disorder
Beyond the preview
Go deeper on PACTR202506840472754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202506840472754.